ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 297 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $744,144 | -57.1% | 29,297 | -31.5% | 0.00% | – |
| Q4 2022 | $1,735,278 | +18.0% | 42,783 | -3.8% | 0.00% | – |
| Q3 2022 | $1,471,000 | -79.2% | 44,491 | -77.8% | 0.00% | -100.0% |
| Q2 2022 | $7,062,000 | -6.7% | 200,585 | +21.9% | 0.00% | 0.0% |
| Q1 2022 | $7,569,000 | -45.7% | 164,587 | -21.7% | 0.00% | -50.0% |
| Q4 2021 | $13,941,000 | +7.7% | 210,282 | +1.4% | 0.00% | 0.0% |
| Q3 2021 | $12,945,000 | -74.1% | 207,346 | -65.6% | 0.00% | -75.0% |
| Q2 2021 | $49,975,000 | +93.3% | 603,418 | +54.8% | 0.01% | +60.0% |
| Q1 2021 | $25,852,000 | -24.5% | 389,864 | -12.7% | 0.01% | -16.7% |
| Q4 2020 | $34,248,000 | +133.5% | 446,341 | +31.0% | 0.01% | +100.0% |
| Q3 2020 | $14,669,000 | +423.5% | 340,653 | +671.3% | 0.00% | +200.0% |
| Q4 2019 | $2,802,000 | – | 44,164 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,303 | $54,386,000 | 28.54% |
| JOHNSON & JOHNSON | 3,260,869 | $216,196,000 | 24.61% |
| ACT CAPITAL MANAGEMENT, LLC | 210,500 | $13,956,000 | 10.09% |
| Aquilo Capital Management, LLC | 700,426 | $46,438,000 | 5.27% |
| WEALTH EFFECTS LLC | 145,960 | $9,677,000 | 4.02% |
| Evolutionary Tree Capital Management, LLC | 115,580 | $7,663,000 | 3.68% |
| ACUTA CAPITAL PARTNERS, LLC | 105,500 | $6,995,000 | 2.94% |
| Privium Fund Management B.V. | 204,393 | $13,766,000 | 2.73% |
| L1 Capital Pty Ltd | 292,735 | $19,408,000 | 2.24% |
| Avidity Partners Management LP | 875,000 | $58,013,000 | 1.23% |